GU Research Network/Urology Cancer Center

Omaha, Nebraska 68130

0 studies enrolling now · 10 studies all time

What they study most

Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent, Renal Cell Carcinoma, UC (Urothelial Cancer), Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter, Urothelial Carcinoma Urethra, Urothelial Carcinoma of the Renal Pelvis and Ureter

Studies at this site

• A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) — Recruiting now
• XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer — Completed
• Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC — Completed
• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer — Completed
• A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) — Completed
• A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma — Stopped early
• Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients — Completed
• Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer — Running, not enrolling
• Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 — Completed